Promotion of cell spreading and migration by Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP) in cooperation with integrins

Journal of Cellular Physiology

Volumn 224, Issue 1, 2010, Pages 195-204

  Mori, Munemasa ^a,b   Murata, Yoji ^a   Kotani, Takenori ^a   Kusakari, Shinya ^a   Ohnishi, Hiroshi ^a   Saito, Yasuyuki ^a   Okazawa, Hideki ^a   Ishizuka, Tamotsu ^b   Mori, Masatomo ^b   Matozaki, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; PROTEIN CDC42; PROTEIN TYROSINE PHOSPHATASE; RAC PROTEIN; RAS PROTEIN; VAV PROTEIN; ENZYME INHIBITOR; FGD1 RELATED CDC42 GEF PROTEIN, HUMAN; FGD1-RELATED CDC42-GEF PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN TYROSINE KINASE; PTPRB PROTEIN, HUMAN; PTPRB PROTEIN, MOUSE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; TYROSINE; VAV2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL MIGRATION; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE SRC; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SRC HOMOLOGY DOMAIN; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; ANGIOGENESIS; ANIMAL; CELL MOTION; CELL SHAPE; CHO CELL; CRICETULUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; MUTATION; PSEUDOPODIUM; TUMOR CELL LINE;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FIBROBLASTS; FIBRONECTINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INTEGRINS; MICE; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-VAV; PSEUDOPODIA; RAC GTP-BINDING PROTEINS; RAS PROTEINS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; RNA INTERFERENCE; SRC-FAMILY KINASES; TRANSFECTION; TYROSINE;

EID: 77952498268     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22122     Document Type: Article

References (52)

1. Ali SA, Steinkasserer A. 1995. PCR-ligation-PCR mutagenesis: A protocol for creating gene fusions and mutations. Biotechniques 18: 746-750.
2. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. 2004. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711. (Pubitemid 38748887)
3. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Møller NP. 2001. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21: 7117-7136.
4. Bar-Sagi D, Hall A. 2000. Ras and Rho GTPases: A family reunion. Cell 103: 227-238.
5. Bäumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D. 2006. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 107: 4754-4762.
6. Borges E, Jan Y, Ruoslahti E. 2000. Platelet-derived growth factor receptor b and vascular endothelial growth factor receptor 2 bind to the b3 integrin through its extracellular domain. J Biol Chem 275: 39867-39873.
7. Brunton VG, MacPherson IR, Frame MC. 2004. Cell adhesion receptors, tyrosine kinases and actin modulators: A complex three-way circuitry. Biochim Biophys Acta 1692: 121-144.
8. 1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang- 1. J Cell Biol 170: 993-1004.
9. Coultas L, Chawengsaksophak K, Rossant J. 2005. Endothelial cells and VEGF in vascular development. Nature 438: 937-945.
10. Davis GE, Senger DR. 2005. Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97: 1093-1107.
11. DeMali KA, Wennerberg K, Burridge K. 2003. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol 15: 572-582.
12. Dominguez MG, Hughes VC, Pan L, Simmons M, Daly C, Anderson K, Noguera-Troise I, Murphy AJ, Valenzuela DM, Davis S, Thurston G, Yancopoulos GD, Gale NW. 2007. Vascular endothelial tyrosine phosphatase (VE-PTP)-nullmice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci USA 104: 3243-3248.
13. Eklund L, Olsen BR. 2006.Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312: 630-641.
14. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420: 629-635.
15. Fachinger G, Deutsch U, Risau W. 1999. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18: 5948-5953.
16. Fukuhara A, Shimizu K, Kawakatsu T, Fukuhara T, Takai Y. 2003. Involvement of nectin-activated Cdc42 small G protein in organization of adherens and tight junctions in Madin-Darby canine kidney cells. J Biol Chem 278: 51885-51893.
17. Gil-Henn H, Elson A. 2003. Tyrosine phosphatase-e activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. J Biol Chem 278: 15579-15586.
18. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271: 695-701. (Pubitemid 126552276)
19. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T, Hatakeyama M. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 279: 17205-17216.
20. Holderfield MT, Hughes CC. 2008. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-b in vascular morphogenesis. Circ Res 102: 637-652.
21. Honda Z, Suzuki T, Hirose N, Aihara M, Shimizu T, Nada S, Okada M, Ra C, Morita Y, Ito K. 1997. Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor-mediated signaling. J Biol Chem 272: 25753-25760.
22. Huveneers S, Danen EH. 2009. Adhesion signaling - Crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059-1069.
23. Jain RK. 2003. Molecular regulation of vessel maturation. Nat Med 9: 685-693.
24. Kanegae Y, Makimura M, Saito I. 1994. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47: 157-166.
25. Katakura Y, Seto P, Miura T, Ohashi H, Teruya K, Shirahata S. 1999. Productivity enhancement of recombinant protein in CHO cells via specific promoter activation by oncogenes. Cytotechnology 31: 103-109. (Pubitemid 29471575)
26. Kawakatsu T, Ogita H, Fukuhara T, Fukuyama T, Minami Y, Shimizu K, Takai Y. 2005. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac. J Biol Chem 280: 4940-4947.
27. Kodama A, Matozaki T, Fukuhara A, Kikyo M, Ichihashi M, Takai Y. 2000. Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol Biol Cell 11: 2565-2575. (Pubitemid 30645027)
28. Kusakari S, Ohnishi H, Jin FJ, Kaneko Y, Murata T, Murata Y, Okazawa H, Matozaki T. 2008. Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47-SHPS-1 system. J Cell Sci 121: 1213-1223.
29. Marignani PA, Carpenter CL. 2001. Vav2 is required for cell spreading. J Cell Biol 154: 177-186.
30. Mellberg S, Dimberg A, Bahram F, Hayashi M, Rennel E, Ameur A, Westholm JO, Larsson E, Lindahl P, Cross MJ, Claesson-Welsh L. 2009. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J 23: 1490-1502.
31. Miyake A, Murata Y, Okazawa H, Ikeda H, Niwayama Y, Ohnishi H, Hirata Y, Matozaki T. 2008. Negative regulation by SHPS-1 of Toll-like receptor-dependent proinflammatory cytokine production in macrophages. Genes Cells 13: 209-219.
32. Miyamoto Y, Yamauchi J, Itoh H. 2003. Src kinase regulates the activation of a novel FGD-1-related Cdc42 guanine nucleotide exchange factor in the signaling pathway from the endothelin A receptor to JNK. J Biol Chem 278: 29890-29900.
33. Miyashita M, Ohnishi H, Okazawa H, Tomonaga H, Hayashi A, Fujimoto TT, Furuya N, Matozaki T. 2004. Promotion of neurite and filopodium formation by CD47: Roles of integrins, Rac, and Cdc42. Mol Biol Cell 15: 3950-3963.
34. Motegi S, Okazawa H, Ohnishi H, Sato R, Kaneko Y, Kobayashi H, Tomizawa K, Ito T, Honma N, Bühring HJ, Ishikawa O, Matozaki T. 2003. Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J 22: 2634-2644.
35. Motegi S, Okazawa H, Murata Y, Kanazawa Y, Saito Y, Kobayashi H, Ohnishi H, Oldenborg PA, Ishikawa O, Matozaki T. 2008. Essential roles of SHPS-1 in induction of contact hypersensitivity of skin. Immunol Lett 121: 52-60.
36. Murata T, Ohnishi H, Okazawa H, Murata Y, Kusakari S, Hayashi Y, Miyashita M, Itoh H, Oldenborg PA, Furuya N, Matozaki T. 2006. CD47 promotes neuronal development through Src- and FRG/Vav2-mediated activation of Rac and Cdc42. J Neurosci 26: 12397-12407.
37. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. 2002. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 21: 4885-4895.
38. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, Bixel MG, Butz S, Vestweber D. 2008. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VEcadherin by leukocytes and by VEGF. J Exp Med 205: 2929-2945.
39. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. 2006. VEGF receptor signalling - In control of vascular function. Nat Rev Mol Cell Biol 7: 359-371.
40. Pallen CJ. 2003. Protein tyrosine phosphatase a (PTPa): A Src family kinase activator and mediator of multiple biological effects. Curr Top Med Chem 3: 821-835.
41. Ren Y, Meng S, Mei L, Zhao ZJ, Jove R, Wu J. 2004. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem 279: 8497-8505.
42. Roskoski R, Jr. 2004. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 324: 1155-1164.
43. Rüegg C, Mariotti A. 2003. Vascular integrins: Pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 60: 1135-1157. (Pubitemid 36791917)
44. Sadakata H, Okazawa H, Sato T, Supriatna Y, Ohnishi H, Kusakari S, Murata Y, Ito T, Nishiyama U, Minegishi T, Harada A, Matozaki T. 2009. SAP-1 is a microvillus-specific protein tyrosine phosphatase that modulates intestinal tumorigenesis. Genes Cells 14: 295-308.
45. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K. 2008. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-537.
46. Servitja JM, Marinissen MJ, Sodhi A, Bustelo XR, Gutkind JS. 2003. Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src. J Biol Chem 278: 34339-34346.
47. 3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18: 882-892.
48. Somanath PR, Ciocea A, Byzova TV. 2009. Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys 53: 53-64.
49. Takai Y, Sasaki T, Matozaki T. 2001. Small GTP-binding proteins. Physiol Rev 81: 153-208.
50. Vestweber D. 2008. VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28: 223-232.
51. Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, Deutsch U, Nottebaum AF, Vestweber D. 2009. VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 185: 657-671.
52. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG. 2004. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13: 341-355.